Dems resurrect a scaled back plan for Medicare drug price negotiations
Only a few days after President Joe Biden seemed to signal that drug pricing reforms were left for dead, Democrats are already circulating plans for a scaled-back version of what they wanted initially, although with more limited Medicare negotiations on a smaller subset of drug prices.
The new plans are part of an attempt to win over support from several Democrats who are on the fence, including Sen. Kyrsten Sinema of Arizona, New Jersey’s Bob Menendez, and both of Delaware’s senators, Chris Coons and Tom Carper.
Unlock this article instantly by becoming a free subscriber.
You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.
